JP2024506904A5 - - Google Patents

Info

Publication number
JP2024506904A5
JP2024506904A5 JP2023548654A JP2023548654A JP2024506904A5 JP 2024506904 A5 JP2024506904 A5 JP 2024506904A5 JP 2023548654 A JP2023548654 A JP 2023548654A JP 2023548654 A JP2023548654 A JP 2023548654A JP 2024506904 A5 JP2024506904 A5 JP 2024506904A5
Authority
JP
Japan
Prior art keywords
pyrimidine
pyrrolidine
carboxylic acid
methylbenzofl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023548654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506904A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/016073 external-priority patent/WO2022174012A1/en
Publication of JP2024506904A publication Critical patent/JP2024506904A/ja
Publication of JP2024506904A5 publication Critical patent/JP2024506904A5/ja
Pending legal-status Critical Current

Links

JP2023548654A 2021-02-11 2022-02-11 治療剤としてのcGAS活性の阻害剤 Pending JP2024506904A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163148201P 2021-02-11 2021-02-11
US63/148,201 2021-02-11
PCT/US2022/016073 WO2022174012A1 (en) 2021-02-11 2022-02-11 INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS

Publications (2)

Publication Number Publication Date
JP2024506904A JP2024506904A (ja) 2024-02-15
JP2024506904A5 true JP2024506904A5 (cg-RX-API-DMAC7.html) 2025-02-19

Family

ID=82837325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023548654A Pending JP2024506904A (ja) 2021-02-11 2022-02-11 治療剤としてのcGAS活性の阻害剤

Country Status (8)

Country Link
US (1) US20240174684A1 (cg-RX-API-DMAC7.html)
EP (1) EP4291188A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024506904A (cg-RX-API-DMAC7.html)
KR (1) KR20230144550A (cg-RX-API-DMAC7.html)
CN (1) CN116997339A (cg-RX-API-DMAC7.html)
AU (1) AU2022218787A1 (cg-RX-API-DMAC7.html)
CA (1) CA3206520A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022174012A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112023020381A2 (pt) * 2021-05-12 2023-11-21 Boehringer Ingelheim Int Derivados de piridina com substituintes cíclicos ligados por c como inibidores de cgas
CN117337292A (zh) 2021-05-12 2024-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的具有N-连接环状取代基的吡啶衍生物
WO2024035622A1 (en) * 2022-08-10 2024-02-15 Bellbrook Labs, Llc INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS
CA3267076A1 (en) * 2022-11-09 2024-05-16 Boehringer Ingelheim International Gmbh CYCLIC PYRIDINE DERIVATIVES USED AS CGAS INHIBITORS
CN121248633A (zh) * 2022-11-09 2026-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的环状苯并咪唑衍生物
WO2025233174A1 (en) 2024-05-08 2025-11-13 Boehringer Ingelheim International Gmbh Benzimidazole derivatives as cgas inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2441958T3 (es) * 2006-07-11 2014-02-07 Janssen Pharmaceutica Nv Moduladores de benzofuro- y benzotienopirimidina del receptor de histamina H4
WO2008074445A1 (en) * 2006-12-18 2008-06-26 Ucb Pharma, S.A. Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof
WO2013115167A1 (ja) * 2012-01-31 2013-08-08 エーザイ・アール・アンド・ディー・マネジメント株式会社 アムバチニブ誘導体
US20200016136A1 (en) * 2017-01-03 2020-01-16 Viiv Healthcare Uk (No. 5) Limited Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
WO2020142729A1 (en) * 2019-01-04 2020-07-09 BellBrook Labs Inhibitors of cgas activity as therapeutic agents

Similar Documents

Publication Publication Date Title
CN111315737B (zh) 经砜吡啶烷基酰胺取代的杂芳基化合物
TWI583681B (zh) 胺基嘧啶基化合物
CN104245671B (zh) 含氮杂环化合物或其盐
CN109071546B (zh) 作为jak抑制剂的吡唑并[1,5-a]吡嗪-4-基衍生物
CN107857755B (zh) 作为trka激酶抑制剂的n-吡咯烷基、n′-吡唑基-脲、硫脲、胍和氰基胍化合物
CN104619698B (zh) 吡咯烷衍生物及其作为补体途径调节剂的用途
CN115485026A (zh) Nlrp3炎体途径抑制剂吡唑并[1,2-d][1,2,4]三嗪-2-基-乙酰胺
JP2022518148A5 (cg-RX-API-DMAC7.html)
JP2023523438A (ja) 置換ヘテロ環式化合物
JP2017525757A5 (cg-RX-API-DMAC7.html)
IL305165A (en) Tyk2 inhibitors and uses thereof
EA033686B1 (ru) Гетероциклические соединения, применимые в качестве модуляторов tnf-альфа
TWI471322B (zh) 新穎醯胺衍生物及其作為醫藥之用途
JP2017505794A5 (cg-RX-API-DMAC7.html)
JP2018512381A5 (cg-RX-API-DMAC7.html)
JP7260488B2 (ja) ジヒドロピリミジン化合物、及び医薬におけるその使用
JP2007510668A (ja) キノリノン化合物を合成する方法
JP2023509495A (ja) RORγt阻害剤、その製造方法及び使用
TW201439066A (zh) 含氮雜環化合物
TW201623239A (zh) 新穎2-胺基-吡啶及2-胺基-嘧啶衍生物及其醫藥用途
CA3216503A1 (en) Phosphorus derivatives as novel sos1 inhibitors
JP2023542205A (ja) 新規化合物
EP4265247A1 (en) Compounds inducing production of proteins by immune cells
AU2021323754A1 (en) Benzylamine derivative, preparation method therefor and use thereof
US20250283038A1 (en) Compounds inducing production of proteins by immune cells